PIRET PHARMA: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
PIRET PHARMA
Largest movements
- Intangible fixed assets -€55,000
down €55,000 (-13.5%), from €407,603 to €352,603
- Cash +€30,265
up €30,265 (+33.0%), from €91,746 to €122,011
mainly Depreciation (+€59,815) and Net result for the year (+€35,490)
- Receivables within one year -€8,992
down €8,992 (-9.4%), from €95,448 to €86,456
of which Trade receivables: -€7,961
- Debts after one year -€48,940
down €48,940 (-14.4%), from €339,454 to €290,514
- Reserves +€35,490
up €35,490 (+41.2%), from €86,183 to €121,674
- Other debts -€13,340
down €13,340 (-8.6%), from €155,640 to €142,300
- Trade debts -€8,605
down €8,605 (-17.6%), from €48,939 to €40,334
- Gross operating margin -€10,704
down €10,704 (-5.9%), from €181,751 to €171,047
- Taxes -€3,299
down €3,299 (-19.7%), from €16,722 to €13,423
- Financial charges +€2,790
up €2,790 (+27.9%), from €10,006 to €12,796
- Staff costs +€2,302
up €2,302 (+4.9%), from €47,256 to €49,557
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €710,417 | €675,213 | -€35,204 | -5.0% |
| Fixed assets | 21/28 | €421,708 | €361,893 | -€59,815 | -14.2% |
| Intangible fixed assets | 21 | €407,603 | €352,603 | -€55,000 | -13.5% |
| Tangible fixed assets | 22/27 | €14,106 | €9,290 | -€4,815 | -34.1% |
| Plant, machinery and equipment | 23 | €11,687 | €8,236 | -€3,451 | -29.5% |
| Furniture and vehicles | 24 | €2,419 | €1,054 | -€1,365 | -56.4% |
| Current assets | 29/58 | €288,709 | €313,320 | +€24,611 | +8.5% |
| Stocks and contracts in progress | 3 | €101,514 | €104,853 | +€3,339 | +3.3% |
| Stocks | 30/36 | €101,514 | €104,853 | +€3,339 | +3.3% |
| Amounts receivable within one year | 40/41 | €95,448 | €86,456 | -€8,992 | -9.4% |
| Trade receivables | 40 | €88,215 | €80,253 | -€7,961 | -9.0% |
| Other amounts receivable | 41 | €7,234 | €6,203 | -€1,031 | -14.3% |
| Cash at bank and in hand | 54/58 | €91,746 | €122,011 | +€30,265 | +33.0% |
| Total equity and liabilities | 10/49 | €710,417 | €675,213 | -€35,204 | -5.0% |
| Equity | 10/15 | €91,183 | €126,674 | +€35,490 | +38.9% |
| Contributions | 10/11 | €5,000 | €5,000 | = | 0.0% |
| Reserves | 13 | €86,183 | €121,674 | +€35,490 | +41.2% |
| Distributable reserves | 133 | €86,183 | €121,674 | +€35,490 | +41.2% |
| Amounts payable | 17/49 | €619,234 | €548,539 | -€70,695 | -11.4% |
| Amounts payable after more than one year | 17 | €339,454 | €290,514 | -€48,940 | -14.4% |
| Financial debts | 170/4 | €339,454 | €290,514 | -€48,940 | -14.4% |
| Amounts payable within one year | 42/48 | €279,157 | €257,478 | -€21,679 | -7.8% |
| Current portion of amounts payable after more than one year | 42 | €52,007 | €56,984 | +€4,977 | +9.6% |
| Trade debts | 44 | €48,939 | €40,334 | -€8,605 | -17.6% |
| Suppliers | 440/4 | €48,939 | €40,334 | -€8,605 | -17.6% |
| Taxes, remuneration and social security | 45 | €22,571 | €17,860 | -€4,711 | -20.9% |
| Taxes | 450/3 | €16,695 | €13,383 | -€3,312 | -19.8% |
| Remuneration and social security | 454/9 | €5,876 | €4,476 | -€1,399 | -23.8% |
| Other amounts payable | 47/48 | €155,640 | €142,300 | -€13,340 | -8.6% |
| Accrued charges and deferred income | 492/3 | €624 | €547 | -€76 | -12.3% |
| Remuneration, social security and pensions | 62 | €47,256 | €49,557 | +€2,302 | +4.9% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €59,379 | €59,815 | +€436 | +0.7% |
| Other operating charges | 640/8 | €626 | €516 | -€110 | -17.6% |
| Non-recurring operating charges | 66A | - | €11 | +€11 | |
| Gross operating margin | 9900 | €181,751 | €171,047 | -€10,704 | -5.9% |
| Operating profit (loss) | 9901 | €74,491 | €61,148 | -€13,343 | -17.9% |
| Financial income | 75/76B | €560 | €562 | +€2 | +0.4% |
| Recurring financial income | 75 | €560 | €562 | +€2 | +0.4% |
| Financial charges | 65/66B | €10,006 | €12,796 | +€2,790 | +27.9% |
| Recurring financial charges | 65 | €10,006 | €12,796 | +€2,790 | +27.9% |
| Profit (loss) for the period before taxes | 9903 | €65,045 | €48,913 | -€16,132 | -24.8% |
| Income taxes | 67/77 | €16,722 | €13,423 | -€3,299 | -19.7% |
| Profit (loss) for the period | 9904 | €48,323 | €35,490 | -€12,833 | -26.6% |
| Profit (loss) for the period to be appropriated | 9905 | €48,323 | €35,490 | -€12,833 | -26.6% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 9 October 2026 via checked.be.